STOCK TITAN

Prudential Financial (PVLA) reports 6.7% beneficial ownership in Palvella Therapeutics

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Prudential Financial, Inc. reported beneficial ownership of common stock of Palvella Therapeutics, Inc. as of June 30, 2026. Prudential and its subsidiaries beneficially owned 962,374 shares of Palvella common stock, representing 6.7% of the class. Prudential reported 0 shares with sole voting or dispositive power, and 826,531 shares with shared voting power and 962,374 shares with shared dispositive power. The stake is held through subsidiaries including Jennison IA with 960,619 shares (6.7%) and PGIM Quantitative Solutions LLC with 1,755 shares. Prudential noted that its clients may have rights to receive dividends or sale proceeds related to these securities.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 962,374 shares Common stock of Palvella Therapeutics beneficially owned by Prudential and subsidiaries
Percent of class 6.7% Portion of Palvella common stock class beneficially owned by Prudential
Shared voting power 826,531 shares Shares of Palvella common where Prudential has shared power to vote
Shared dispositive power 962,374 shares Shares of Palvella common where Prudential has shared power to dispose
Jennison IA holdings 960,619 shares Palvella shares beneficially owned via Prudential subsidiary Jennison IA (6.7%)
PGIM Quant Solutions holdings 1,755 shares Palvella shares beneficially owned via PGIM Quantitative Solutions LLC
Date of beneficial ownership 06/30/2026 Date as of which Palvella ownership figures are reported
beneficially owned financial
"Amount beneficially owned: 962,374 (b) | Percent of class: 6.7 %"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared power to vote or to direct the vote: 826,531"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared power to dispose or to direct the disposition of: 962,374"
Parent Holding Company financial
"Prudential Financial, Inc. is a Parent Holding Company and the indirect parent"
Investment Company Act of 1940 regulatory
"investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership in Palvella Therapeutics (PVLA) did Prudential Financial report?

Prudential Financial reported beneficial ownership of 962,374 shares of Palvella Therapeutics common stock, representing 6.7% of the outstanding class as of June 30, 2026.

How much voting power does Prudential Financial have in Palvella Therapeutics (PVLA)?

Prudential reported 0 shares with sole voting power and 826,531 shares with shared voting power in Palvella Therapeutics, reflecting its influence being exercised jointly, not individually.

Which Prudential subsidiaries hold Palvella Therapeutics (PVLA) shares and how many?

Prudential identified Jennison IA as holding 960,619 shares (6.7%) and PGIM Quantitative Solutions LLC as holding 1,755 shares of Palvella Therapeutics common stock.

What does 6.7% beneficial ownership in PVLA mean in this filing?

Beneficial ownership of 6.7% means Prudential and its subsidiaries are deemed to beneficially own that portion of Palvella’s common stock, considering their power to vote or dispose of 962,374 shares on behalf of clients.

Do Prudential’s clients have rights to Palvella Therapeutics (PVLA) dividends or sale proceeds?

Yes. Prudential stated that its clients may have the right to receive or direct dividends and proceeds from the sale of the Palvella shares referenced in this Schedule 13G.

Does Prudential Financial have sole dispositive power over its Palvella Therapeutics (PVLA) stake?

No. Prudential reported 0 shares with sole dispositive power and 962,374 shares with shared dispositive power, indicating decisions are made jointly, often for clients’ accounts.





697947109

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



PRUDENTIAL FINANCIAL INC
Signature:/s/ Richard Baker
Name/Title:Second Vice President
Date:08/10/2026